Kanyini Vascular Collaboration (664)
The Kanyini Vascular Collaboration (KVC) was established by Aboriginal and Torres Strait Islanders and non-Indigenous health researchers, policy advisors, health economists, clinicians and community controlled health services with the aim of improving health outcomes for Aboriginal and Torres Strait Islander peoples living with chronic disease (www.kvc.org.au). Currently funded by an Australian Primary Health Care Research Institute Centre of Research Excellence Grant, the KVC contributes to improving health outcomes by identifying systemic barriers to health care, implementing and evaluating health systems/ services interventions, as well as building capacity within primary health care services. By establishing a coherent policy agenda and a clear strategy for dissemination, findings from the KVC research are translated into health practice.
Supported by an Indigenous Caucus and national advisory structures, the KVC has already completed a number of key projects including the Kanyini Vascular Audit, Kanyini Qualitative Study and the Kanyini Polypill Trial. Building on this foundational research, the KVC is currently focused on three primary studies. The “Home Based Outreach Chronic Disease Management Exploratory Study” aims to assess the feasibility, acceptability and appropriateness of a home based outreach service to Aboriginal and Torres Strait Islander peoples with chronic disease, their families and their Primary Health Care Service. A recently funded NHMRC Project Grant, “The Validation of a Culturally-specific Measure to Identify Depression in Aboriginal and Torres Strait Islander People with or without Chronic Disease” aims to validate a culturally adapted, free-to-use screening tool for depression among Aboriginal and Torres Strait Islander patients attending Primary Care Services. Drawing on all of the current and previous KVC research, the study entitled “Towards a Well-Being Model for Aboriginal and Torres Strait Islander Peoples” is focused on improving the quality of care, health outcomes and importantly the quality of life for Aboriginal and Torres Strait Islander peoples living with chronic disease.